STJ

Study Results Show Significant Overall Cost Savings with St. Jude Medical Quadripolar System

[Business Wire] – St. Jude Medical, Inc. , a global medical device company, today announced that data presented during Heart Rhythm 2014, the Heart Rhythm Society’s Annual Scientific Sessions, found that the use of quadripolar leads reduced the number of moreView todays social media effects on STJView the latest stocks trending across Twitter. Click to view dashboardSee who St. is […]

5:35 pm St. Jude Medical: Pacemaker and defibrillator patients adhering to remote monitoring with St. Jude Medical’s Merlin technology saw more than double survival rate

moreView todays social media effects on STJView the latest stocks trending across Twitter. Click to view dashboardSee who St. is hiring next, click here to view […]

Pacemaker and Defibrillator Patients Adhering to Remote Monitoring with St. Jude Medical’s Merlin Technology Saw More than Double Survival Rate

[Business Wire] – St. Jude Medical, Inc. , a global medical device company, announced that data presented during a Late Breaking Clinical Trial Session during Heart Rhythm 2014, the Heart Rhythm Society’s Annual Scientific Sessions, found an association moreView todays social media effects on STJView the latest stocks trending across Twitter. Click to view dashboardSee who St. is hiring […]

Can This Struggling Industry Bounce Back?

moreView todays social media effects on STJView the latest stocks trending across Twitter. Click to view dashboardSee who St. is hiring next, click here to view […]

St. Jude Medical Continues Its Quadripolar Technology Leadership at HRS 2014

[Business Wire] – St. Jude Medical, Inc. , a global medical device company, is the leader in quadripolar technology with the only cardiac resynchronization therapy system approved in the U.S. moreView todays social media effects on STJView the latest stocks trending across Twitter. Click to view dashboardSee who St. is hiring next, click here to view […]

St. Jude Medical Announces TOCCASTAR Clinical Trial Meets Primary Safety and Efficacy Endpoints at Heart Rhythm 2014

[Business Wire] – St. Jude Medical, Inc. , a global medical device company, today announced results of the TOCCASTAR clinical trial at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions in San Francisco. moreView todays social media effects on STJView the latest stocks trending across Twitter. Click to view dashboardSee who St. is hiring next, click here […]